Enter search term

2021 Lyme disease testing resolutions

Dec 3, 2020

2021 Lyme disease testing resolutions

Make a difference, help patients get treated faster

  • Improve detection of early Lyme disease
  • Replace outdated Lyme disease immunoblots
  • Increase overall lab workflow and efficiency


With less than 30 days left of 2020, now is the time to get ready for the 2021 Lyme disease season by implementing ZEUS Scientific's Borrelia Modified Two-Tiered Testing (MTTT™) algorithm. The clock is ticking away for using immunoblots for the second-tier of Lyme disease testing.  As your choices in 2021 for Lyme disease immunoblot testing are now more limited, make the choice to implement a more accurate Lyme disease testing algorithm by choosing ZEUS Borrelia MTTT™.

Are you running Lyme disease immunoblot confirmation testing in-house?
Do not get left behind in 2021 using an outdated Lyme disease testing algorithm.  MarDx® Lyme disease western blot has been discontinued by the manufacturer.  Let the experts at ZEUS assist your laboratory and replace difficult-to-read immunoblots all together with the new and improved and only FDA-cleared Borrelia MTTT™ algorithm method of testing for Lyme disease.

Are you currently sending out samples for Lyme disease immunoblot confirmation testing?
You can now perform both first-tier and second-tier testing right in your laboratory.  Simplify your workflow and eliminate send outs.



ZEUS Borrelia MTTT™ uses two rounds of ELISA tests, enabling simple and flexible first-tier and second-tier testing in-house with an automation-friendly approach. This translates to simplified Lyme disease testing processes and improved detection of early Lyme disease. Earlier diagnosis equals earlier treatment. 


The ZEUS Borrelia MTTT™ reduces turnaround time, allowing patients to access much-needed treatment earlier. Without early treatment, Lyme disease can have a devastating impact on patients. 


Our updated algorithm detected up to 30% more clinically confirmed positive patients in acute early Lyme disease, the critical time to correctly identify and treat!  Reducing the number of missed clinically positive patient samples especially in early Lyme disease stages 1 and 2 can make a real difference in a person’s life.


Trust the experts in Lyme disease testing.
Test with Confidence. Test with ZEUS.


Learn more about Lyme disease and ZEUS’s Borrelia Modified Two-Tiered Testing (MTTT™) algorithm at zeuslyme.com.


Get started on next year’s plans, partner with ZEUS and get ahead of the 2021 Lyme disease season today!



The ZEUS ScientificTeam

Back Share